Don’t Throw The Baby Out With The Bathwater: The Benefits Of PSA Testing

Speaker: Dr. Andrew Loblaw
Original Date: Thursday November 6, 2014

In response to the recommendations against PSA testing by the Canadian Task Force on Preventative Health Care, this Expert Angle webinar highlights the benefits of PSA testing with Dr. Andrew Loblaw.  In particular, Dr. Loblaw discusses:
  • the importance of active surveillance and its adoption in Canada
  • the need to measure baseline PSA to determine prostate cancer risk
  • the use of modeling data to augment cohort data



Dr. Andrew Loblaw

andrew_loblaw.jpgDr. Andrew Loblaw is a Radiation Oncologist, Clinician Scientist and Associate Professor in the Departments of Radiation Oncology and Health Policy Management and Evaluation at the University of Toronto. He has a Masters in Clinical Epidemiology from the University of Toronto and is a graduate of the Royal College’s Clinician Investigator Program. Dr. Loblaw’s clinical practice focuses on prostate cancer. He has a research interest in improving outcomes for men with prostate cancer, particularly determining the optimal timing of salvage androgen deprivation therapy, and the outcomes of active surveillance and image-guided radiotherapy. Dr. Loblaw is an Ontario Association of Radiation Oncology Clinician Scientist and a Scientist at the Sunnybrook Research Institute. He is the North American Editor for Clinical Oncology and the Co-Chair of the American Society of Clinical Oncology’s Genitourinary Advisory Group and Co-Chair of the GU group for Cancer Care Ontario’s Program in Evidence-Based Care. He has authored over 150 peer-reviewed papers and has been awarded grant funding of over $12 million dollars.

About Canadian Cancer Survivor Network (CCSN)

Prostate Cancer Canada is co-hosting this Expert Angle with CCSN.

CCSN is an organization committed to developing public policy on cancer issues and increasing advocacy for optimal cancer care and follow-up. CCSN works to connect patients, survivors and other stakeholder groups with decision makers and the wider community to engage in discussion and to act on evidence-based best practices to alleviate the medical, emotional, financial and social costs of cancer and encourage research on ways to overcome barriers to optimal cancer care and follow-up for survivors in Canada.

About Expert Angle

Expert AngleExpert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
 
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.

 

Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More

Prostate Cancer Canada launches first national program in radioligand therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.
More


Click here for news archive